Viewing StudyNCT00219219



Ignite Creation Date: 2024-05-05 @ 12:01 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00219219
Status: COMPLETED
Last Update Posted: 2015-04-14
First Post: 2005-09-07

Brief Title: Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases
Sponsor: Novartis
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-09
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2006-10
Completion Date Type: None
First Submit Date: 2005-09-07
First Submit QC Date: September 16 2005
Study First Post Date: 2005-09-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-04-13
Last Update Post Date: 2015-04-14
Last Update Post Date Type: ESTIMATED